ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - ASCO 2022: The ImPrint Immune Signature to Identify Patients With High-Risk eBC Who May Benefit From PD-1 Checkpoint Inhibition in I-SPY2
By
ASCO 2022 Conference Coverage
FEATURING
Lorenza Mittempergher
By
ASCO 2022 Conference Coverage
FEATURING
Lorenza Mittempergher
37 views
June 8, 2022
Comments 0
Login to view comments.
Click here to Login
Breast